Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial-Reference-Cited by-同舟云学术

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy: Post Hoc Analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Trial

Published:2007-04-04 Issue:5 Volume:18 Page:1540-1546
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Eijkelkamp Wouter B.A.,Zhang Zhongxin,Remuzzi Giuseppe,Parving Hans-Henrik,Cooper Mark E.,Keane William F.,Shahinfar Shahnaz,Gleim Gilbert W.,Weir Matthew R.,Brenner Barry M.,de Zeeuw Dick

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference17 articles.

1. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL

2. Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy

3. Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

4. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

5. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial

Cited by 265 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney transcriptomics signature of prospective rapid diabetic kidney disease progression;2024-07-04

2. Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions;Biomedicines;2024-05-15

3. Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease;Cochrane Database of Systematic Reviews;2024-04-29

4. Mitochondria-derived reactive oxygen species contribute to synergistic interaction of diabetes and hypertension in causing chronic kidney injury;American Journal of Physiology-Renal Physiology;2024-03-01

5. Biomarkers and Precision Medicine in Diabetes;Textbook of Diabetes;2024-01-12